1. Home
  2. NMRA vs CNXN Comparison

NMRA vs CNXN Comparison

Compare NMRA & CNXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • CNXN
  • Stock Information
  • Founded
  • NMRA 2019
  • CNXN 1982
  • Country
  • NMRA United States
  • CNXN United States
  • Employees
  • NMRA N/A
  • CNXN N/A
  • Industry
  • NMRA
  • CNXN Catalog/Specialty Distribution
  • Sector
  • NMRA
  • CNXN Consumer Discretionary
  • Exchange
  • NMRA Nasdaq
  • CNXN Nasdaq
  • Market Cap
  • NMRA 1.7B
  • CNXN 1.9B
  • IPO Year
  • NMRA 2023
  • CNXN 1998
  • Fundamental
  • Price
  • NMRA $2.05
  • CNXN $71.22
  • Analyst Decision
  • NMRA Strong Buy
  • CNXN
  • Analyst Count
  • NMRA 6
  • CNXN 0
  • Target Price
  • NMRA $20.67
  • CNXN N/A
  • AVG Volume (30 Days)
  • NMRA 6.3M
  • CNXN 72.1K
  • Earning Date
  • NMRA 03-06-2025
  • CNXN 02-12-2025
  • Dividend Yield
  • NMRA N/A
  • CNXN 0.56%
  • EPS Growth
  • NMRA N/A
  • CNXN 14.84
  • EPS
  • NMRA N/A
  • CNXN 3.40
  • Revenue
  • NMRA N/A
  • CNXN $2,789,687,000.00
  • Revenue This Year
  • NMRA N/A
  • CNXN $0.71
  • Revenue Next Year
  • NMRA N/A
  • CNXN $5.15
  • P/E Ratio
  • NMRA N/A
  • CNXN $20.95
  • Revenue Growth
  • NMRA N/A
  • CNXN N/A
  • 52 Week Low
  • NMRA $1.83
  • CNXN $57.47
  • 52 Week High
  • NMRA $21.00
  • CNXN $77.19
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 20.26
  • CNXN 53.27
  • Support Level
  • NMRA $2.12
  • CNXN $68.14
  • Resistance Level
  • NMRA $2.44
  • CNXN $70.71
  • Average True Range (ATR)
  • NMRA 0.39
  • CNXN 1.45
  • MACD
  • NMRA -0.31
  • CNXN 0.25
  • Stochastic Oscillator
  • NMRA 2.26
  • CNXN 88.24

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

About CNXN PC Connection Inc.

PC Connection Inc is a provider of information technology solutions. It provides products such as computer systems, software and peripheral equipment, networking communications, and other products and accessories that company purchase from manufacturers and distributors. The company also offers services involving design, configuration, and implementation of IT solutions. It conducts business operations through three business segments namely Connection Business Solutions, Connection Enterprise Solutions, and Connection Public Sector Solutions. The company generates maximum revenue Connection Enterprise Solutions segment.

Share on Social Networks: